Sudeep Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve the Audited Standalone and Consolidated ....
SUDEEPPHRM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sudeep Pharma Ltd has informed exchanges that a Board meeting is scheduled for 21st May 2026. The meeting will consider and approve the Audited Standalone and Consolidated Financial Results for Q4 and the year ended 31st March 2026. The Board will also consider recommending a Final Dividend for FY 2025-26. The company has closed its trading window for insiders from 1st April 2026 till 48 hours after the financial results are declared (till 23rd May 2026). This is a standard regulatory intimation under SEBI Listing Regulations.
This is a routine procedural filing announcing a future board meeting. No specific financial data or outcomes are disclosed. Investors should await the actual results announcement expected after 21st May 2026 to assess company performance.